Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Josef Stehlik, MD
University of Utah
Study Chair - Michael Olymbios, MD
Natera, Inc.
Study Director - Palak Shah, MD
Inova Health Care Services
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of California, San Diego
San Diego, California, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Utah
Salt Lake City, Utah, United States
- Inova Heart and Vascular Institute
Falls Church, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2022
- Primary completion
- 2 Oct 2024
- Completion
- 2 Oct 2024
- Last update posted
- 29 Oct 2024
- Registered enrollment
- 147
- Registry id
- NCT05309382
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.